Prevention of doxorubicin-induced Cardiotoxicity by pharmacological non-hypoxic myocardial preconditioning based on Docosahexaenoic Acid (DHA) and carvedilol direct antioxidant effects: study protocol for a pilot, randomized, double-blind, controlled trial (CarDHA trial)

Peer Review reports

Original Submission
14 Mar 2019	Submitted	Original manuscript
14 May 2019	Reviewed	Reviewer Report - JD Schwalm
5 Jun 2019	Author responded	Author comments - Rodrigo Carrasco
Resubmission - Version 2
5 Jun 2019	Submitted	Manuscript version 2
Publishing
5 Dec 2019	Editorially accepted
4 Feb 2020	Article published	10.1186/s13063-019-3963-6

Back to article page